Employees: 01 (2023.0)Legal category: 5485Size: PMECreation date: 2014-12-18 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHATEL-SUR-MOSELLE (88330), Vosges
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE BERNARD : revenue, balance sheet and financial ratios
SELARL PHARMACIE BERNARD is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHATEL-SUR-MOSELLE (88330),
this company of category PME
shows in 2024 a net income positive of 61 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE BERNARD (SIREN 808493167)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
61 349 €
50 840 €
69 958 €
65 650 €
59 489 €
57 858 €
50 867 €
64 833 €
71 854 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE BERNARD generates positive net income of 61 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 72 k€ -> 61 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
61 349 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 33%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
33.289%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
67.113%
Solvency indicators evolution SELARL PHARMACIE BERNARD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
417.308
278.437
208.182
155.875
129.442
86.821
63.034
47.031
33.289
Financial autonomy
17.456
24.382
30.906
36.827
41.437
50.153
55.182
62.193
67.113
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
33.292024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-9 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE BERNARD (33.29) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
67.11%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+12 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE BERNARD (67.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 157.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
157.857
Liquidity indicators evolution SELARL PHARMACIE BERNARD
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
196.198
224.336
288.641
241.379
350.681
217.248
172.314
172.845
157.857
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
157.862024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average
In 2024, the liquidity ratio of SELARL PHARMACIE BERNARD (157.86) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE BERNARD in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE BERNARD is estimated at
856 477 €
(range 596 437€ - 1 281 339€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
596k€856k€1281k€
856 477 €Range: 596 437€ - 1 281 339€
NAF 5 année 2024
Valuation method used
Net Income Multiple
61 349 €
×
14.0x
=856 477 €
Range: 596 437€ - 1 281 339€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE BERNARD with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE BERNARD
What is the revenue of SELARL PHARMACIE BERNARD ?
The revenue of SELARL PHARMACIE BERNARD is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE BERNARD profitable?
Yes, SELARL PHARMACIE BERNARD generated a net profit of 61 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE BERNARD ?
The headquarters of SELARL PHARMACIE BERNARD is located in CHATEL-SUR-MOSELLE (88330), in the department Vosges.
Where to find the tax return of SELARL PHARMACIE BERNARD ?
The tax return of SELARL PHARMACIE BERNARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE BERNARD operate?
SELARL PHARMACIE BERNARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart